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 Abstract: 
Objectives: We sought to evaluate outcomes of stent implantation (SI) for recurrent coarctation of the 
aorta (RC) following the Norwood operation.  
Background: RC is common following the Norwood operation. Balloon angioplasty (BA) is standard 
treatment but may result in unsatisfactory relief of RC.  SI may improve RC, but outcome data are limited.  
Methods: We performed a multi-center retrospective study of patients who underwent SI for RC between 
the Norwood operation and Fontan completion. Outcomes were examined, including procedural success, 
serious adverse events (SAE), and freedom from re-intervention. A core laboratory was utilized to review 
angiograms. Coarctation Index (CI) was calculated before and after SI.  Paired t-test and Wilcoxon 
signed-rank test were used to compare pre- and post-SI variables.  
Results: Thirty-three patients at 8 centers underwent SI for RC at a median age of 5 months (IQR 4.1, 
13.3) and weight of 5.9 kg (5.2, 8.6). Aortic arch gradient improved from 20 (15, 24) to 0 (0, 2) mmHg 
following SI (p<0.0001). The median CI improved from 0.54 (0.43, 0.62) to 0.97 (0.89, 1.06) following SI 
(p<0.0001). There were no procedural deaths but SAEs occurred in 12 (36%) patients. During a median 
follow-up duration of 29.7 months (6.8, 48.0), freedom from death or heart transplant was 82%, and from 
re-intervention was 45%, with median time to re-intervention of 20.1 months (11.4, 40.3).  
Conclusions: SI for treatment of RC in patients after the Norwood operation provides excellent acute 
relief of obstruction. Intra-procedural hemodynamic instability is common and re-intervention is frequent at 
mid-term follow-up.  
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Introduction: 
 Postoperative recurrent coarctation (RC) of the aorta is reported in 9–37% of patients following 
the Norwood procedure for hypoplastic left heart syndrome (HLHS) and its variants (1,2).  RC may be 
poorly tolerated in patients with HLHS and a single systemic right ventricle, potentially leading to 
ventricular dilation and dysfunction, increased tricuspid valve regurgitation, and a clinically relevant and 
harmful imbalance between the pulmonary and systemic circulations (3,4).  For these reasons and others, 
RC has been shown to be a risk factor for long-term morbidity and mortality in single ventricle (SV) 
patients (3,5,6). 
 
Transcatheter treatment of RC in SV patients using balloon angioplasty (BA) has been well described 
(2,7).  While BA is generally considered the first-line treatment for SV patients with RC, BA may result in 
inadequate acute relief of aortic obstruction, non-durable relief of obstruction (e.g. early recurrence), or 
both (8-11).  In these cases, treatment options include repeat BA, aortic stent implantation (SI) or surgical 
re-intervention.  SI has the potential for improved acute relief of aortic obstruction and more durable 
results, avoiding the need for re-operation, but may be associated with a greater procedural complications 
compared to BA.  Moreover, SI will necessarily require future stent re-dilation to match somatic growth, 
thus making transcatheter re-intervention a requirement.  Existing data supporting SI post Norwood-
related RC are limited to case reports and small single center series (11-13).  Therefore, we sought to 
investigate a large multi-center cohort of patients undergoing SI for treatment of post-Norwood RC – prior 
to Fontan completion – to evaluate acute procedural outcomes and clinical outcomes at mid-term follow-
up. 
 
Materials and Methods: 
We performed a multi-institutional retrospective study of SV patients who underwent SI for RC between 
the Norwood operation and Fontan completion at 8 participating centers between 2007 and 2015.  All co-
investigators were members of the Pediatric and Congenital Interventional Cardiology Early Career 
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Society (PICES).  Institutional Review Board approval was obtained at each participating center.   All SV 
patients who underwent SI for RC following the Norwood operation and prior to Fontan completion were 
included in the study.  Baseline clinical characteristics, including cardiac diagnoses, surgical history and 
prior transcatheter interventions were collected on all patients.  Echocardiographic data, catheterization-
derived hemodynamic data, and angiographic data before, during and after SI were collected.  
Echocardiograms used for data collection were those closest to the SI and preferably within 1 week 
before and 1 week after SI procedure. Additionally, the technique for SI was collected and categorized for 
each patient as prograde (percutaneous venous access with catheter course anterograde across the neo-
aortic valve and arch), retrograde (percutaneous arterial access with catheter course retrograde across 
aortic arch), trans-carotid (carotid artery access via surgical cut-down and catheter course anterograde 
across aortic arch), or hybrid (surgical access to a major systemic artery such as the transverse arch).  
A core laboratory was used for angiography review and assessment (Syngo Dynamics workplace 
(version: 8.0.0SPC), Siemens Medical Solutions USA Inc., Ann Arbor, Michigan, USA).  A single 
interventional pediatric cardiologist at University of Iowa Children’s Hospital (OA) reviewed all 
angiograms.  The core lab was blinded to the rest of the data and outcomes. Using a standard calibration 
process, measurements of the aortic arch were made using the lateral angiographic projection. A 
Coarctation Index (CI) was calculated for each patient, utilizing the aortic diameter at the coarctation site 
(minimal diameter) and the diameter of the descending aorta at the diaphragm (AortaCoarctation / 
AortaDiaphragm) before and after SI.  Additionally, the type of RC was classified as either discrete or long-
segment based on whether the length of narrowing is ≤3 mm vs. >3 mm respectively.  The diameter of the 
nominal stent compared to the narrowest aortic diameter and descending aorta were also calculated.  
Angiographic assessment included potential intervention-related complications, such as aortic wall injury, 
stent malposition or embolization, and jailing of brachiocephalic arteries.   
 
Procedural success was defined as a post intervention peak-to-peak gradient across the aortic arch 
gradient of ≤ 10 mmHg (3,14).  Serious adverse events (SAE) were recorded and defined based on 
published literature on catheterization risk score for pediatrics (15).  Hemodynamic compromise was 
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defined as hemodynamic instability requiring an intervention (for example, inotropic medication or 
cardiopulmonary resuscitation). Patient follow-up data was collected through the time of the Fontan 
completion, specifically including any re-intervention on the aortic arch and clinical outcomes. 
 
Statistical Analysis 
Data are presented as frequency with percentage for categorical variables and median with interquartile 
range (IQR) for continuous variables. Paired t-test and Wilcoxon signed-rank test were used to compare 
pre- and post-SI variables. Freedom from re-intervention and freedom from death or heart transplant was 
computed using Kaplan-Meier method.  Analyses were performed using software SAS version 9.4 and 
statistical significance set at P-value <0.05. 
 
Results: 
A total of 33 patients met the inclusion criteria and comprised the study cohort (Table 1).  The majority of 
patients (n= 29, 88%) underwent BA before SI; 21 of 29 underwent BA during a separate procedure and 
13 patients during the same procedure as SI, of which 4 patients for the second time.  Thirteen patients 
(39%) underwent SI between the Norwood procedure and superior cavopulmonary anastomosis (SCPA) 
while 20 (61%) underwent SI between SCPA and Fontan completion.  The type of RC was discrete in 
52% and long-segment in 48% of patients (Figure 1-A and B).  The approach for SI was prograde in 21 
patients (64%), retrograde in 5 (15%), hybrid in 5 (15%), and trans-carotid in 2 (6%).  
 
Acute Outcomes 
Successful SI was possible in 100% of patients based on our hemodynamic definition (Figure 1- C and D) 
although in one patient, initial stent embolized and another one was successfully placed.   The median 
peak-to-peak gradient across the coarctation site improved from 20 (15, 24) to 0 (0, 2) mmHg following SI 
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(p<0.0001) (Figure 2-a). By echocardiography, median uncorrected peak instantaneous pressure 
gradients by Doppler decreased from 34 mmHg (20, 44) to 15 mmHg (5, 18) (p<0.0001) (Figure 2-b).  
There was no statistically significant change in the degree of atrioventricular valve regurgitation or 
systemic ventricular function after SI (Figure 3-a, 3-b). Angiographically, after SI, the median narrowest 
aortic arch diameter increased from 3.8 mm (3.3, 4.4) to 6.6 mm (6.0, 7.5) (p<0.0001) (Table 2).  The 
median CI improved from 0.54 (0.43, 0.62) to 0.97 (0.89, 1.06) after SI (p<0.0001) (Figure 2-c, 2-d). The 
nominal stent diameters were approximately equal to the descending aortic diameter and twice the 
coarctation diameter (Table 2). 
 
Procedural SAE were observed in 12 patients (36%). Hemodynamic compromise occurred in 7 patients, 
with 6 of the patients having undergone SI from a prograde approach and 1 from a retrograde approach.  
In 3 of these 7 patients, hemodynamic insult progressed into bradycardiac arrest requiring 
cardiopulmonary resuscitation.  All patients were successfully resuscitated with no procedural mortality or 
need for initiation of extracorporial membrane oxygenation (ECMO) support.  There was no association 
between timing of SI (before or after SCPA) and hemodynamic instability.   
 
Other SAEs included blood loss requiring transfusion (n=3, 9%), AV block (eventually treated with 
pacemaker placement at the time of SCPA; n=1, 3%), access-related vascular injury (n=1, 3%) and stent 
embolization (n=1, 3%).  In the single case of aortic stent embolization, the stent was subsequently 
affixed to the vascular wall (e.g. implanted) in the descending aorta and a second stent was successfully 
implanted across the coarctation site.  No patients experienced angiographically-evident aortic wall injury. 
 
Minor adverse events included jailing of the left subclavian artery, which occurred in 11 patients (33%).  
All patients had unobstructed flow into the left subclavian artery through the bare metal stent on post SI 
angiography.  One patient (3%) had minor stent malposition (stent was not centered over the stenosis 
area) that did not affect the procedure outcome and 1 (3%) patient had transient junctional rhythm that 
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resolved spontaneously.  There were 2 patients already on ECMO support at the time of SI.  No peri-
procedural complications occurred in this group, however, both patients subsequently died unrelated to 
the SI procedure. 
 
Mid-Term Outcomes 
During a median follow-up duration of 28.3 months (6.7, 44.5), freedom from death or heart transplant 
was 82%.  Freedom from re-intervention on the aortic stent was 81.1% at 6 months, 72.1% at 12 months, 
and 43.3% at 24 months with a median time to re-intervention of 20.1 months (11.4, 40.3) (Figure 4). 
Amongst those patients not on mechanical support (ECMO) at the time of catheterization for SI, freedom 
from death or transplant was 85.1% during a median follow-up of 31 months (6.9, 51.4).  Freedom from 
re-intervention was 81.7% at 6 months, 73.5% at 12 months, and 50.6% at 24 months with a median time 
for re-intervention of 24.6 months (11.4, 40.3). Of the 18 patients (54%) who underwent re-intervention, 
the indication was somatic growth in 9 (50%), in-stent stenosis in 3 (17%), re-stenosis in 3 (17%), and 
stent fracture in 3 (17%).  Among the 3 patients with stent fracture, 2 had a significant gradient seen on 
echocardiogram and the third stent fracture was found incidentally on CXR.  All patients with stent 
fracture underwent re-intervention with balloon angioplasty of the existing stent.  In one case, stent 
integrity was lost following BA resulting in distal embolization of a stent fragment which was successfully 
removed percutaneously during the same procedure. The other 2 patients with stent fracture but intact 
integrity underwent successful BA without complications.  Six patients (18%) underwent a second re-
intervention, 2 (33%) for in-stent stenosis, 2 (33%) for re-stenosis, and 2 (33%) for somatic growth.   
 
During the study period, 18 (55%) patients had undergone Fontan completion, 5 (15%) were awaiting 
Fontan completion, 2 (6%) were awaiting second stage palliation and 1 (3%) underwent cardiac 
transplantation secondary to severe atrioventricular valve regurgitation and progressive heart failure.  In 
addition, mortality occurred in 5 (15%) patients unrelated to SI procedure with median time of 26 days 
(25, 146) from SI.  Causes of death were multiorgan failure following cardiac arrest in 2, respiratory failure 
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in 1, intraoperative death during cavopulmonary anastomosis surgery in 1, and the last patient was 
electively made DNR secondary to poor candidacy for second stage repair in a patient with known 
genetic syndrome and extracardiac anomalies.  Two subjects (6%) were lost to follow-up.   
 
Discussion: 
In this multi-center study of SV patients with recurrent coarctation treated with transcatheter stent 
implantation prior to Fontan completion, we demonstrated a high rate of technical success and procedural 
efficacy.  Notably, SI for RC was associated with a significant rate of SAE, including hemodynamic 
compromise in 21%.  As anticipated, re-intervention was common at mid-term follow-up, largely for 
purposes of stent dilation to match interval somatic growth.  To our knowledge, this is the first multi-center 
collaborative to evaluate acute and mid-term outcomes of SI for RC in SV patients. 
 
RC is a common cause of morbidity and mortality in SV patients after the Norwood procedure (3,5,6). 
Although typically attempted first, BA to treat RC is not uniformly acutely successful and often does not 
provide durable gradient relief.  Studies have suggested a high success rate of BA but variable freedom 
of re-intervention (2,7,16).  Factors found to contribute to successful BA were larger balloon size, lower 
initial peak-to-peak gradient and larger diameter of descending aorta in one study (7).  Factors associated 
with higher rates of RC after BA included smaller patients and older age at the time of Norwood 
procedure (16).  In our study, 88% of patients who ultimately underwent SI for RC had previously 
undergone BA, which is consistent with estimates from prior studies that 15-20% of patients would be 
non-responders to BA (7,16).  This also suggested BA being the first line treatment of RC for most 
operators and SI would be considered if unsatisfactory BA results. Several possible mechanisms to 
explain the ineffectiveness of aortic BA include vessel recoil, vessel torsion (compared to true stenosis) 
and external compression.  In these circumstances, SI is likely to provide improved procedural success, 
when compared to BA.   
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Surgical revision of the aortic arch is an alternative therapy for RC, either in lieu of BA, or following BA 
with unsatisfactory results. A recent study reviewed the surgical outcomes after RC repair including both 
single and biventricular repair.  Although post-Norwood cases made up only a small portion of the study 
cohort (n=17), this sub-group responded satisfactorily to surgical re-intervention, with freedom from 
repeat re-intervention of 94% at a median follow up of 7.2 years (17). Despite the efficacy of surgical re-
intervention, this approach carries inherent risks that are distinct from SI, including those related to repeat 
sternotomy, cardiopulmonary bypass, sternal wound, and deep tissue dissection.  Although most of the 
post-Norwood cases included in this study were performed at the time of SCPA, thus avoiding an 
additional surgery, arch revision does add risks to the SCPA procedure, including the potential for greater 
support times, with the risk of inducing greater lung (inflammatory) pathology placing the new SCPA 
circulation at risk.  Further, delaying relief of arch obstruction to the planned SCPA surgery could place 
the post-Norwood patient at risk for greater morbidity or mortality.     
 
The most notable SAE in our cohort was hemodynamic instability, which was seen in 21% of patients. 
Importantly, this was most often seen using the prograde approach and is similar to the risk of 
hemodynamic compromise reported with BA using a prograde approach in single ventricle patients (8,13).  
The prograde approach, which typically involves femoral venous access and a catheter course across the 
tricuspid and neo-aortic valves to gain access to the aortic arch, has the advantage of utilizing femoral 
venous access, which is preferred to femoral arterial access since SI often requires a relatively large bore 
(6-8 French) sheath.  However, because of the catheter/wire/sheath course, the tricuspid and neoaortic 
valves may be temporarily stented open, which can result in acute tricuspid and neoaortic valves 
insufficiency associated with significantly diminished ventricular ejection and inadequate systemic blood 
pressure and cardiac output.  Additionally, the effect of stretching the atrioventricular node or atrial tissue 
could contribute to atrioventricular block and/or bradycardia which may worsen the resultant hypotension 
and low output (13).  Therefore, a retrograde approach, carotid artery cut-down, or hybrid approach may 
reduce hemodynamic instability during SI, which may be beneficial especially in patients with pre-
procedural evidence of depressed ventricular function or significant tricuspid valve regurgitation (18,19). 
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Other consideration includes advancing premounted stent without long introducer to avoid the additional 
stretching effect of the long sheath (13).  Access-related vascular injury is another important SAE 
following SI, especially in patients with large bore arterial access (11,12).  In our cohort, access related 
vascular injury was relatively uncommon, occurring in only 1 patient.  This patient had pulse loss after the 
catheterization, without risk to the limb.   
 
Over 50% of our study cohort required re-intervention during a relatively short follow-up period.   This rate 
is higher than what has been reported with BA (39%) for a similar group of patients (2).  Re-intervention 
following SI is partially anticipated as stents placed in small children invariably require dilation to match 
interval somatic growth.  The intervals between dilation would be anticipated to increase over time, but 
early after implantation in small and young children, this interval would be expected to be rather short 
(months to a year or two).  In our cohort, ~25% of patients required re-intervention because of somatic 
growth.  Fortunately, stent dilation with BA is typically a straight forward procedure that requires smaller 
sheaths compared to SI, and therefore is typically performed from a retrograde approach, with a lower 
incidence of procedural hemodynamic instability and SAE (20).  More importantly, however, we found that 
an additional 25% of our study cohort required re-intervention for in-stent stenosis, residual arch 
obstruction, or stent fracture.  Both in-stent stenosis and stent fracture are recognized long-term sequelae 
following SI in congenital heart disease, not just for RC.  Thus, close monitoring is recommended after SI 
in all CHD patients (21,22).  These outcomes are less predictable than patient-stent mismatch due to 
somatic growth, and can be more challenging to manage, often requiring repeat stent implantation.  Given 
our small sample size, we were unable to identify stent specific risk factors for development of in-stent 
stenosis or stent fracture.  
An important consideration when treating recurrent coarctation in young patients is stent choice.  The 
ideal stent would be ultimately dilatable to a diameter matching that of the typical adult aorta. In our 
cohort, 4 stents (12%) were not able to meet this ideal state.  Historically these stents would require 
surgical transection or removal as patients reach adult size.  More recently, in vitro and animal studies 
have shown the ability to intentionally fracture, or un-zip, small stents using high pressure balloons from a 
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percutaneous approach (23,24).  Clinical data from late intentional stent fracture in the aorta, in either the 
coarctation or single ventricle populations, do not yet exist.  Nevertheless, we conclude that in this cohort, 
while stents capable of dilation to adult aortic diameters are preferred, the use of medium diameter 
premounted stents may not be a critical limiting factor for SI in small children.  Moreover, future availability 
of bioabsorbable stent platforms in this working range might shift practice, hypothetically allowing for 
similar procedural efficacy without the need for early or recurrent stent re-intervention (25).  This 
population would be an ideal candidate group in which to study the applications of such technology. 
 
An important limitation of the current literature on the treatment of recurrent coarctation is a lack of 
descriptive clinical outcomes following repeat balloon angioplasty or surgical repair, especially in single 
ventricle patients.  Future studies including these outcomes, especially if able to directly compare 
medium-term results of SI, repeat BA, and surgical repair - for the treatment of RC in SV patients - would 
add greatly to the understanding of how to manage these complex and high-risk patients with recurrent 
aortic obstruction after the Norwood operation. 
 
Limitations 
The retrospective design, small sample size and short follow-up duration are the main limitations of this 
study.  The indication for re-intervention was reported by the participating sites but subsequent re-
intervention angiograms were not reviewed in the core lab. Other limitations include the heterogeneity of 
patient population and the broad number of different types of stents used. Nevertheless, the multi-center 
collaborative nature of this cohort may help to partially offset the limitations in statistical power.  Other 
limitation includes the non-standardized approach of treatment that reflects the multi-center nature of this 
study. 
 
Conclusion: 
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Stent implantation for treatment of recurrent coarctation in single ventricle patients prior to Fontan 
completion provides excellent acute relief of aortic arch obstruction. This includes those patients that 
demonstrated an inadequate response to balloon angioplasty alone.  Procedural adverse events are 
common, especially intra-procedural hemodynamic compromise when utilizing a prograde approach, but 
did not result in the need for mechanical support or mortality.  Arch re-intervention is common during mid-
term follow-up.  Long-term outcomes, including the fate of the aortic stent years beyond implantation, are 
necessary to study. 
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FIGURES LEGENDS:  
Figure 1: A- A discrete coarctation of the aorta and C- Post coarctation SI angiogram. B- Long segment 
coarctation of the aorta and D- Post SI angiogram. SI: Stent implantation.  
Figure 2: a- Drop in peak-to-peak catheterization gradient post SI.  b- Peak instantaneous 
echocardiogram gradient improvement on post SI. c- Angiographic improvement of the coarctation 
diameter post SI. d- Improvement of CI post SI.  SI: stent implantation, PIG: peak instantaneous gradient.  
Figure 3: a- Echocardiographic single ventricular function pre- and post SI.  b- The degree of 
atrioventricular valve regurgitation pre- and post SI.  AVVR: atrioventricular valve regurgitation.  
Figure 4: Kaplan-Meier curve of freedom of Heart Transplant/ Death and Re-intervention. 
 
 
Table 1: Baseline Characteristics of the cohort. 
HLHS: Hypoplastic left heart syndrome, MA: mitral valve atresia, AA: aortic valve atresia, MS: mitral valve 
stenosis, AS: aortic valve stenosis, RV: right ventricle, LV: left ventricle, BT shunt: Blalock Taussig shunt, 
SI: stent implantation, SCPA: Superior cavo-pulmonary anastomosis, ECMO: extracorporeal membrane 
oxygenation.  
Table 2: Angiographic and procedural details. 
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Figure 1: A- A discrete coarctation of the aorta and C- Post coarctation SI angiogram. B- Long segment 
coarctation of the aorta and D- Post SI angiogram. SI: Stent implantation.  
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Figure 2: a- Drop in peak-to-peak catheterization gradient post SI.  b- Peak instantaneous echocardiogram 
gradient improvement on post SI. c- Angiographic improvement of the coarctation diameter post SI. d- 
Improvement of CI post SI.  SI: stent implantation, PIG: peak instantaneous gradient.  
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Figure 3: a- Echocardiographic single ventricular function pre- and post SI.  b- The degree of atrioventricular 
valve regurgitation pre- and post SI.  AVVR: atrioventricular valve regurgitation.  
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Figure 4: Kaplan-Meier curve of freedom of Heart Transplant/ Death and Re-intervention.  
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Table 1: Baseline Characteristics of the cohort. 
 Median (IQR) or percentages 
Number of patients 33 
Cardiac diagnosis HLHS 26 (79%) 
    MA/AA 14 (42%) 
    MS/AA 2 (6%)  
    MA/AS 4 (12%) 
    MS/AS 6 (18%)     
Other systemic RV 6 (18%) 
Other systemic LV 1 (3%) 
Gender (Male) 23 (70%) 
Genetic disorder 2 (6%) 
Type of systemic-pulmonary shunt Sano shunt 23 (70%) 
BT shunt 10 (30%) 
Age at procedure, months 5.0 (4.1-13.3) 
Weight at procedure, kg 5.9 (5.2-8.6) 
Interval from BA to SI, days 70 (50-162) 
Interval time from Norwood to SI, months 4.5 (3.1-11.3)  
Surgical stage at procedure Before SCPA 13 (39%) 
After SCPA 20 (61%) 
Presenting to lab on ECMO support 2 (6%) 
HLHS: Hypoplastic left heart syndrome, MA: mitral valve atresia, AA: aortic valve atresia, MS: mitral valve 
stenosis, AS: aortic valve stenosis, RV: right ventricle, LV: left ventricle, BT shunt: Blalock Taussig shunt, 
SI: stent implantation, SCPA: Superior cavo-pulmonary anastomosis, ECMO: extracorporeal membrane 
oxygenation.  
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Table 2: Angiographic and procedural details. 
 Median (IQR) or percentage 
Type of coarctation Discrete 17 (52%) 
Long segment 16 (48%) 
Baseline narrowest aortic diameter (mm) 3.8 (3.3-4.4) 
Coarctation index 0.54 (0.43-0.62) 
Implanted stent diameter to coarctation ratio 2.1 (1.8-2.6) 
Implanted stent diameter to descending ratio 1.1 (1.0-1.2) 
Largest implantation sheath size (Fr) 7 (6-8) 
     -Prograde: 7 
     -Retrograde: 6 
     -Hybrid:8 
     -Carotid: 8 
Implanted stent diameter (mm) 8 (7-9) 
     -Between first and second stage: 7 
     -Between second and third stage: 8.5 
Stent length (mm) 19 (min 12, max 30) 
Close cell design stent 23 (70%) 
Non-premounted stents 
Genesis XD 
Mega LD 
Max LD 
Premounted stents 
Premounted Palmaz stents 
Bard Valeo 
Express 
Formula 
Zues II 
22 (67%) 
18 
3 
1 
11 (33%) 
5 
2 
2 
1 
1 
Fluoroscopy time, minutes 25.5 (10.4-34.5)  
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 Abstract: 
Objectives: We sought to evaluate outcomes of stent implantation (SI) for recurrent coarctation of the 
aorta (RC) following the Norwood operation.  
Background: RC is common following the Norwood operation. Balloon angioplasty (BA) is standard 
treatment but may result in unsatisfactory relief of RC.  SI may improve RC, but outcome data are limited.  
Methods: We performed a multi-center retrospective study of patients who underwent SI for RC between 
the Norwood operation and Fontan completion. Outcomes were examined, including procedural success, 
serious adverse events (SAE), and freedom from re-intervention. A core laboratory was utilized to review 
angiograms. Coarctation Index (CI) was calculated before and after SI.  Paired t-test and Wilcoxon 
signed-rank test were used to compare pre- and post-SI variables.  
Results: Thirty-three patients at 8 centers underwent SI for RC at a median age of 5 months (IQR 4.1, 
13.3) and weight of 5.9 kg (5.2, 8.6). Aortic arch gradient improved from 20 (15, 24) to 0 (0, 2) mmHg 
following SI (p<0.0001). The median CI improved from 0.54 (0.43, 0.62) to 0.97 (0.89, 1.06) following SI 
(p<0.0001). There were no procedural deaths but SAEs occurred in 12 (36%) patients. During a median 
follow-up duration of 29.7 months (6.8, 48.0), freedom from death or heart transplant was 82%, and from 
re-intervention was 45%, with median time to re-intervention of 20.1 months (11.4, 40.3).  
Conclusions: SI for treatment of RC in patients after the Norwood operation provides excellent acute 
relief of obstruction. Intra-procedural hemodynamic instability is common and re-intervention is frequent at 
mid-term follow-up.  
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Introduction: 
 Postoperative recurrent coarctation (RC) of the aorta is reported in 9–37% of patients following 
the Norwood procedure for hypoplastic left heart syndrome (HLHS) and its variants (1,2).  RC may be 
poorly tolerated in patients with HLHS and a single systemic right ventricle, potentially leading to 
ventricular dilation and dysfunction, increased tricuspid valve regurgitation, and a clinically relevant and 
harmful imbalance between the pulmonary and systemic circulations (3,4).  For these reasons and others, 
RC has been shown to be a risk factor for long-term morbidity and mortality in single ventricle (SV) 
patients (3,5,6). 
 
Transcatheter treatment of RC in SV patients using balloon angioplasty (BA) has been well described 
(2,7).  While BA is generally considered the first-line treatment for SV patients with RC, BA may result in 
inadequate acute relief of aortic obstruction, non-durable relief of obstruction (e.g. early recurrence), or 
both (8-11).  In these cases, treatment options include repeat BA, aortic stent implantation (SI) or surgical 
re-intervention.  SI has the potential for improved acute relief of aortic obstruction and more durable 
results, avoiding the need for re-operation, but may be associated with a greater procedural complications 
compared to BA.  Moreover, SI will necessarily require future stent re-dilation to match somatic growth, 
thus making transcatheter re-intervention a requirement.  Existing data supporting SI post Norwood-
related RC are limited to case reports and small single center series (11-13).  Therefore, we sought to 
investigate a large multi-center cohort of patients undergoing SI for treatment of post-Norwood RC – prior 
to Fontan completion – to evaluate acute procedural outcomes and clinical outcomes at mid-term follow-
up. 
 
Materials and Methods: 
We performed a multi-institutional retrospective study of SV patients who underwent SI for RC between 
the Norwood operation and Fontan completion at 8 participating centers between 2007 and 2015.  All co-
investigators were members of the Pediatric and Congenital Interventional Cardiology Early Career 
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Society (PICES).  Institutional Review Board approval was obtained at each participating center.   All SV 
patients who underwent SI for RC following the Norwood operation and prior to Fontan completion were 
included in the study.  Baseline clinical characteristics, including cardiac diagnoses, surgical history and 
prior transcatheter interventions were collected on all patients.  Echocardiographic data, catheterization-
derived hemodynamic data, and angiographic data before, during and after SI were collected.  
Echocardiograms used for data collection were those closest to the SI and preferably within 1 week 
before and 1 week after SI procedure. Additionally, the technique for SI was collected and categorized for 
each patient as prograde (percutaneous venous access with catheter course anterograde across the neo-
aortic valve and arch), retrograde (percutaneous arterial access with catheter course retrograde across 
aortic arch), trans-carotid (carotid artery access via surgical cut-down and catheter course anterograde 
across aortic arch), or hybrid (surgical access to a major systemic artery such as the transverse arch).  
A core laboratory was used for angiography review and assessment (Syngo Dynamics workplace 
(version: 8.0.0SPC), Siemens Medical Solutions USA Inc., Ann Arbor, Michigan, USA).  A single 
interventional pediatric cardiologist at University of Iowa Children’s Hospital (OA) reviewed all 
angiograms.  The core lab was blinded to the rest of the data and outcomes. Using a standard calibration 
process, measurements of the aortic arch were made using the lateral angiographic projection. A 
Coarctation Index (CI) was calculated for each patient, utilizing the aortic diameter at the coarctation site 
(minimal diameter) and the diameter of the descending aorta at the diaphragm (AortaCoarctation / 
AortaDiaphragm) before and after SI.  Additionally, the type of RC was classified as either discrete or long-
segment based on whether the length of narrowing is ≤3 mm vs. >3 mm respectively.  The diameter of the 
nominal stent compared to the narrowest aortic diameter and descending aorta were also calculated.  
Angiographic assessment included potential intervention-related complications, such as aortic wall injury, 
stent malposition or embolization, and jailing of brachiocephalic arteries.   
 
Procedural success was defined as a post intervention peak-to-peak gradient across the aortic arch 
gradient of ≤ 10 mmHg (3,14).  Serious adverse events (SAE) were recorded and defined based on 
published literature on catheterization risk score for pediatrics (15).  Hemodynamic compromise was 
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defined as hemodynamic instability requiring an intervention (for example, inotropic medication or 
cardiopulmonary resuscitation). Patient follow-up data was collected through the time of the Fontan 
completion, specifically including any re-intervention on the aortic arch and clinical outcomes. 
 
Statistical Analysis 
Data are presented as frequency with percentage for categorical variables and median with interquartile 
range (IQR) for continuous variables. Paired t-test and Wilcoxon signed-rank test were used to compare 
pre- and post-SI variables. Freedom from re-intervention and freedom from death or heart transplant was 
computed using Kaplan-Meier method.  Analyses were performed using software SAS version 9.4 and 
statistical significance set at P-value <0.05. 
 
Results: 
A total of 33 patients met the inclusion criteria and comprised the study cohort (Table 1).  The majority of 
patients (n= 29, 88%) underwent BA before SI; 21 of 29 underwent BA during a separate procedure and 
13 patients during the same procedure as SI, of which 4 patients for the second time.  Thirteen patients 
(39%) underwent SI between the Norwood procedure and superior cavopulmonary anastomosis (SCPA) 
while 20 (61%) underwent SI between SCPA and Fontan completion.  The type of RC was discrete in 
52% and long-segment in 48% of patients (Figure 1-A and B).  The approach for SI was prograde in 21 
patients (64%), retrograde in 5 (15%), hybrid in 5 (15%), and trans-carotid in 2 (6%).  
 
Acute Outcomes 
Successful SI was possible in 100% of patients based on our hemodynamic definition (Figure 1- C and D) 
although in one patient, initial stent embolized and another one was successfully placed.   The median 
peak-to-peak gradient across the coarctation site improved from 20 (15, 24) to 0 (0, 2) mmHg following SI 
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(p<0.0001) (Figure 2-a). By echocardiography, median uncorrected peak instantaneous pressure 
gradients by Doppler decreased from 34 mmHg (20, 44) to 15 mmHg (5, 18) (p<0.0001) (Figure 2-b).  
There was no statistically significant change in the degree of atrioventricular valve regurgitation or 
systemic ventricular function after SI (Figure 3-a, 3-b). Angiographically, after SI, the median narrowest 
aortic arch diameter increased from 3.8 mm (3.3, 4.4) to 6.6 mm (6.0, 7.5) (p<0.0001) (Table 2).  The 
median CI improved from 0.54 (0.43, 0.62) to 0.97 (0.89, 1.06) after SI (p<0.0001) (Figure 2-c, 2-d). The 
nominal stent diameters were approximately equal to the descending aortic diameter and twice the 
coarctation diameter (Table 2). 
 
Procedural SAE were observed in 12 patients (36%). Hemodynamic compromise occurred in 7 patients, 
with 6 of the patients having undergone SI from a prograde approach and 1 from a retrograde approach.  
In 3 of these 7 patients, hemodynamic insult progressed into bradycardiac arrest requiring 
cardiopulmonary resuscitation.  All patients were successfully resuscitated with no procedural mortality or 
need for initiation of extracorporial membrane oxygenation (ECMO) support.  There was no association 
between timing of SI (before or after SCPA) and hemodynamic instability.   
 
Other SAEs included blood loss requiring transfusion (n=3, 9%), AV block (eventually treated with 
pacemaker placement at the time of SCPA; n=1, 3%), access-related vascular injury (n=1, 3%) and stent 
embolization (n=1, 3%).  In the single case of aortic stent embolization, the stent was subsequently 
affixed to the vascular wall (e.g. implanted) in the descending aorta and a second stent was successfully 
implanted across the coarctation site.  No patients experienced angiographically-evident aortic wall injury. 
 
Minor adverse events included jailing of the left subclavian artery, which occurred in 11 patients (33%).  
All patients had unobstructed flow into the left subclavian artery through the bare metal stent on post SI 
angiography.  One patient (3%) had minor stent malposition (stent was not centered over the stenosis 
area) that did not affect the procedure outcome and 1 (3%) patient had transient junctional rhythm that 
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resolved spontaneously.  There were 2 patients already on ECMO support at the time of SI.  No peri-
procedural complications occurred in this group, however, both patients subsequently died unrelated to 
the SI procedure. 
 
Mid-Term Outcomes 
During a median follow-up duration of 28.3 months (6.7, 44.5), freedom from death or heart transplant 
was 82%.  Freedom from re-intervention on the aortic stent was 81.1% at 6 months, 72.1% at 12 months, 
and 43.3% at 24 months with a median time to re-intervention of 20.1 months (11.4, 40.3) (Figure 4). 
Amongst those patients not on mechanical support (ECMO) at the time of catheterization for SI, freedom 
from death or transplant was 85.1% during a median follow-up of 31 months (6.9, 51.4).  Freedom from 
re-intervention was 81.7% at 6 months, 73.5% at 12 months, and 50.6% at 24 months with a median time 
for re-intervention of 24.6 months (11.4, 40.3). Of the 18 patients (54%) who underwent re-intervention, 
the indication was somatic growth in 9 (50%), in-stent stenosis in 3 (17%), re-stenosis in 3 (17%), and 
stent fracture in 3 (17%).  Among the 3 patients with stent fracture, 2 had a significant gradient seen on 
echocardiogram and the third stent fracture was found incidentally on CXR.  All patients with stent 
fracture underwent re-intervention with balloon angioplasty of the existing stent.  In one case, stent 
integrity was lost following BA resulting in distal embolization of a stent fragment which was successfully 
removed percutaneously during the same procedure. The other 2 patients with stent fracture but intact 
integrity underwent successful BA without complications.  Six patients (18%) underwent a second re-
intervention, 2 (33%) for in-stent stenosis, 2 (33%) for re-stenosis, and 2 (33%) for somatic growth.   
 
During the study period, 18 (55%) patients had undergone Fontan completion, 5 (15%) were awaiting 
Fontan completion, 2 (6%) were awaiting second stage palliation and 1 (3%) underwent cardiac 
transplantation secondary to severe atrioventricular valve regurgitation and progressive heart failure.  In 
addition, mortality occurred in 5 (15%) patients unrelated to SI procedure with median time of 26 days 
(25, 146) from SI.  Causes of death were multiorgan failure following cardiac arrest in 2, respiratory failure 
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in 1, intraoperative death during cavopulmonary anastomosis surgery in 1, and the last patient was 
electively made DNR secondary to poor candidacy for second stage repair in a patient with known 
genetic syndrome and extracardiac anomalies.  Two subjects (6%) were lost to follow-up.   
 
Discussion: 
In this multi-center study of SV patients with recurrent coarctation treated with transcatheter stent 
implantation prior to Fontan completion, we demonstrated a high rate of technical success and procedural 
efficacy.  Notably, SI for RC was associated with a significant rate of SAE, including hemodynamic 
compromise in 21%.  As anticipated, re-intervention was common at mid-term follow-up, largely for 
purposes of stent dilation to match interval somatic growth.  To our knowledge, this is the first multi-center 
collaborative to evaluate acute and mid-term outcomes of SI for RC in SV patients. 
 
RC is a common cause of morbidity and mortality in SV patients after the Norwood procedure (3,5,6). 
Although typically attempted first, BA to treat RC is not uniformly acutely successful and often does not 
provide durable gradient relief.  Studies have suggested a high success rate of BA but variable freedom 
of re-intervention (2,7,16).  Factors found to contribute to successful BA were larger balloon size, lower 
initial peak-to-peak gradient and larger diameter of descending aorta in one study (7).  Factors associated 
with higher rates of RC after BA included smaller patients and older age at the time of Norwood 
procedure (16).  In our study, 88% of patients who ultimately underwent SI for RC had previously 
undergone BA, which is consistent with estimates from prior studies that 15-20% of patients would be 
non-responders to BA (7,16).  This also suggested BA being the first line treatment of RC for most 
operators and SI would be considered if unsatisfactory BA results. Several possible mechanisms to 
explain the ineffectiveness of aortic BA include vessel recoil, vessel torsion (compared to true stenosis) 
and external compression.  In these circumstances, SI is likely to provide improved procedural success, 
when compared to BA.   
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Surgical revision of the aortic arch is an alternative therapy for RC, either in lieu of BA, or following BA 
with unsatisfactory results. A recent study reviewed the surgical outcomes after RC repair including both 
single and biventricular repair.  Although post-Norwood cases made up only a small portion of the study 
cohort (n=17), this sub-group responded satisfactorily to surgical re-intervention, with freedom from 
repeat re-intervention of 94% at a median follow up of 7.2 years (17). Despite the efficacy of surgical re-
intervention, this approach carries inherent risks that are distinct from SI, including those related to repeat 
sternotomy, cardiopulmonary bypass, sternal wound, and deep tissue dissection.  Although most of the 
post-Norwood cases included in this study were performed at the time of SCPA, thus avoiding an 
additional surgery, arch revision does add risks to the SCPA procedure, including the potential for greater 
support times, with the risk of inducing greater lung (inflammatory) pathology placing the new SCPA 
circulation at risk.  Further, delaying relief of arch obstruction to the planned SCPA surgery could place 
the post-Norwood patient at risk for greater morbidity or mortality.     
 
The most notable SAE in our cohort was hemodynamic instability, which was seen in 21% of patients. 
Importantly, this was most often seen using the prograde approach and is similar to the risk of 
hemodynamic compromise reported with BA using a prograde approach in single ventricle patients (8,13).  
The prograde approach, which typically involves femoral venous access and a catheter course across the 
tricuspid and neo-aortic valves to gain access to the aortic arch, has the advantage of utilizing femoral 
venous access, which is preferred to femoral arterial access since SI often requires a relatively large bore 
(6-8 French) sheath.  However, because of the catheter/wire/sheath course, the tricuspid and neoaortic 
valves may be temporarily stented open, which can result in acute tricuspid and neoaortic valves 
insufficiency associated with significantly diminished ventricular ejection and inadequate systemic blood 
pressure and cardiac output.  Additionally, the effect of stretching the atrioventricular node or atrial tissue 
could contribute to atrioventricular block and/or bradycardia which may worsen the resultant hypotension 
and low output (13).  Therefore, a retrograde approach, carotid artery cut-down, or hybrid approach may 
reduce hemodynamic instability during SI, which may be beneficial especially in patients with pre-
procedural evidence of depressed ventricular function or significant tricuspid valve regurgitation (18,19). 
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Other consideration includes advancing premounted stent without long introducer to avoid the additional 
stretching effect of the long sheath (13).  Access-related vascular injury is another important SAE 
following SI, especially in patients with large bore arterial access (11,12).  In our cohort, access related 
vascular injury was relatively uncommon, occurring in only 1 patient.  This patient had pulse loss after the 
catheterization, without risk to the limb.   
 
Over 50% of our study cohort required re-intervention during a relatively short follow-up period.   This rate 
is higher than what has been reported with BA (39%) for a similar group of patients (2).  Re-intervention 
following SI is partially anticipated as stents placed in small children invariably require dilation to match 
interval somatic growth.  The intervals between dilation would be anticipated to increase over time, but 
early after implantation in small and young children, this interval would be expected to be rather short 
(months to a year or two).  In our cohort, ~25% of patients required re-intervention because of somatic 
growth.  Fortunately, stent dilation with BA is typically a straight forward procedure that requires smaller 
sheaths compared to SI, and therefore is typically performed from a retrograde approach, with a lower 
incidence of procedural hemodynamic instability and SAE (20).  More importantly, however, we found that 
an additional 25% of our study cohort required re-intervention for in-stent stenosis, residual arch 
obstruction, or stent fracture.  Both in-stent stenosis and stent fracture are recognized long-term sequelae 
following SI in congenital heart disease, not just for RC.  Thus, close monitoring is recommended after SI 
in all CHD patients (21,22).  These outcomes are less predictable than patient-stent mismatch due to 
somatic growth, and can be more challenging to manage, often requiring repeat stent implantation.  Given 
our small sample size, we were unable to identify stent specific risk factors for development of in-stent 
stenosis or stent fracture.  
An important consideration when treating recurrent coarctation in young patients is stent choice.  The 
ideal stent would be ultimately dilatable to a diameter matching that of the typical adult aorta. In our 
cohort, 4 stents (12%) were not able to meet this ideal state.  Historically these stents would require 
surgical transection or removal as patients reach adult size.  More recently, in vitro and animal studies 
have shown the ability to intentionally fracture, or un-zip, small stents using high pressure balloons from a 
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percutaneous approach (23,24).  Clinical data from late intentional stent fracture in the aorta, in either the 
coarctation or single ventricle populations, do not yet exist.  Nevertheless, we conclude that in this cohort, 
while stents capable of dilation to adult aortic diameters are preferred, the use of medium diameter 
premounted stents may not be a critical limiting factor for SI in small children.  Moreover, future availability 
of bioabsorbable stent platforms in this working range might shift practice, hypothetically allowing for 
similar procedural efficacy without the need for early or recurrent stent re-intervention (25).  This 
population would be an ideal candidate group in which to study the applications of such technology. 
 
An important limitation of the current literature on the treatment of recurrent coarctation is a lack of 
descriptive clinical outcomes following repeat balloon angioplasty or surgical repair, especially in single 
ventricle patients.  Future studies including these outcomes, especially if able to directly compare 
medium-term results of SI, repeat BA, and surgical repair - for the treatment of RC in SV patients - would 
add greatly to the understanding of how to manage these complex and high-risk patients with recurrent 
aortic obstruction after the Norwood operation. 
 
Limitations 
The retrospective design, small sample size and short follow-up duration are the main limitations of this 
study.  The indication for re-intervention was reported by the participating sites but subsequent re-
intervention angiograms were not reviewed in the core lab. Other limitations include the heterogeneity of 
patient population and the broad number of different types of stents used. Nevertheless, the multi-center 
collaborative nature of this cohort may help to partially offset the limitations in statistical power.  Other 
limitation includes the non-standardized approach of treatment that reflects the multi-center nature of this 
study. 
 
Conclusion: 
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Stent implantation for treatment of recurrent coarctation in single ventricle patients prior to Fontan 
completion provides excellent acute relief of aortic arch obstruction. This includes those patients that 
demonstrated an inadequate response to balloon angioplasty alone.  Procedural adverse events are 
common, especially intra-procedural hemodynamic compromise when utilizing a prograde approach, but 
did not result in the need for mechanical support or mortality.  Arch re-intervention is common during mid-
term follow-up.  Long-term outcomes, including the fate of the aortic stent years beyond implantation, are 
necessary to study. 
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FIGURES LEGENDS:  
Figure 1: A- A discrete coarctation of the aorta and C- Post coarctation SI angiogram. B- Long segment 
coarctation of the aorta and D- Post SI angiogram. SI: Stent implantation.  
Figure 2: a- Drop in peak-to-peak catheterization gradient post SI.  b- Peak instantaneous 
echocardiogram gradient improvement on post SI. c- Angiographic improvement of the coarctation 
diameter post SI. d- Improvement of CI post SI.  SI: stent implantation, PIG: peak instantaneous gradient.  
Figure 3: a- Echocardiographic single ventricular function pre- and post SI.  b- The degree of 
atrioventricular valve regurgitation pre- and post SI.  AVVR: atrioventricular valve regurgitation.  
Figure 4: Kaplan-Meier curve of freedom of Heart Transplant/ Death and Re-intervention. 
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Table 1: Baseline Characteristics of the cohort. 
HLHS: Hypoplastic left heart syndrome, MA: mitral valve atresia, AA: aortic valve atresia, MS: mitral valve 
stenosis, AS: aortic valve stenosis, RV: right ventricle, LV: left ventricle, BT shunt: Blalock Taussig shunt, 
SI: stent implantation, SCPA: Superior cavo-pulmonary anastomosis, ECMO: extracorporeal membrane 
oxygenation.  
Table 2: Angiographic and procedural details. 
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